Watch: As India Starts Vaccine Roll Out, Concerns Over Covaxin Remain
This article has been removed following an ex parte injunction of a court in Telangana, delivered following a petition filed by Bharat Biotech Ltd.
Seraj Ali
Jan 21 2021
Advertisement
Real journalism holds power accountable
Since 2015, The Wire has done just that.
But we can continue only with your support.
This article has been removed following an ex parte injunction of a court in Telangana, delivered following a petition filed by Bharat Biotech Ltd.
Bharat Biotech has also filed a Rs 100 crore defamation case against The Wire, its editors, and 10 staffers and contributors.
The Wire will be fighting this injunction and defamation plaint.
Advertisement
The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.
Advertisement
Make a contribution to Independent Journalism
Advertisement
